Founder of the Rosenwald Foundation
Widely considered a leading figure in the field of biotechnology and pharmaceutical investing, Lindsay Rosenwald has worked with some of the most innovative companies in the world, bringing their industry-changing products into the next phases of development. With a diversified background as a health care management consultant and practicing physician, Dr. Rosenwald entered the booming market for biotechnology in the mid-1980s as a Wall Street financial and medical analyst. Lindsay Rosenwald subsequently launched an investment company, which he quickly grew into a multifaceted source of financing, management consulting, and other necessary services for the drug development sector.
Lindsay Rosenwald has distinguished his group of companies by identifying and financing a vast array of biotechnology firms with potentially revolutionary drugs in clinical trials. Among these, he has founded or invested in Cypress Bioscience,Coronado Biosciences, Enzymed, Keryx Bio-pharmaceuticals,Ziopharm Oncology,and Cougar Biotechnology, which sold to Johnson & Johnson in 2009 for nearly $1 billion. At the top of Genetic Engineering & Biotechnology News’ 2002 list of Molecular Millionaires, Dr. Rosenwald has also gained distinction as a Director of Keryx Biopharmaceuticals, a cofounder of OpusPoint Partners, and a philanthropic leader.
The founder of the Rosenwald Foundation, Lindsay Rosenwald has donated millions of dollars to a number of worthy charitable initiatives through this organization. Dr. Rosenwald is also an Honorary Member of the Board of Visitors at the Smeal College of Business at The Pennsylvania State University and has been part of the Columbia-Presbyterian Health Sciences Advisory Council.Dr. Rosenwald is also a member of the Board of Visitors of the Temple University School of Medicine.
Lindsay Rosenwald's Companies
Lindsay Rosenwald's Publications